Clinical Trials Directory

Trials / Completed

CompletedNCT06354270

A Clinical Study to Evaluate the Anti-Sensitivity Efficacy of a Stannous Fluoride Toothpaste in a Population of Dentin Hypersensitivity Sufferers

An 8-Week, Randomized, Controlled, Examiner-Blind, Clinical Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste for the Relief of Dentin Hypersensitivity in a Population of Dentin Hypersensitivity Sufferers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
115 (actual)
Sponsor
HALEON · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to confirm the clinical Dentin Hypersensitivity (DH) efficacy of a 0.454 percent (%) Stannous Fluoride (SnF2) toothpaste.

Detailed description

This will be a single center, 8-week, randomized, controlled, examiner-blind, 2-treatment arm, parallel design, stratified (by maximum baseline Schiff sensitivity score of the two selected 'test teeth') clinical study to evaluate the anti-sensitivity efficacy of a 0.454% SnF2 toothpaste in healthy participants with DH. The clinical efficacy of the 0.454% SnF2 toothpaste (test toothpaste) will be compared with that of a reference toothpaste, a commercially available, regular fluoride toothpaste with no known anti-sensitivity properties (negative control). Sufficient participants will be screened to randomize approximately 110 participants to investigational product (approximately 55 per treatment group) and to ensure approximately 100 evaluable participants complete the entire study (approximately 50 per treatment group).

Conditions

Interventions

TypeNameDescription
DRUGStannous fluoride toothpasteToothpaste containing 0.454 % weight/weight (w/w) SnF2.
DRUGRegular fluoride toothpaste (Crest Cavity Protection)Regular fluoride toothpaste containing 1100 parts per million (ppm) fluoride.

Timeline

Start date
2024-04-11
Primary completion
2024-06-23
Completion
2024-06-23
First posted
2024-04-09
Last updated
2025-06-25
Results posted
2025-06-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06354270. Inclusion in this directory is not an endorsement.